🔬 Third-party verified peptides · Free Express Post over $200 CAD
Pantheon Peptides
Anti-Aging4 cited studies

Livagen

KEDA liver bioregulator peptide studied for chromatin remodeling, cellular repair, and healthy-aging research.

Also known as: KEDA peptide
SummaryMechanismDosingSafetyStudies
Research use only — not for human consumption.

What it is

Livagen (KEDA; Lys-Glu-Asp-Ala) is a short peptide bioregulator associated with liver cell health, gene-expression regulation, chromatin reactivation, and aging-related cellular support.

Mechanism of action

Livagen is studied as a tissue-specific peptide bioregulator. Source literature describes effects on chromatin reactivation, gene expression, and physiologic function in aging and pathology models.

Evidence summary

Evidence is drawn from peptide-bioregulator and aging literature, including liver-polypeptide complex and KEDA studies. Human-grade dosing evidence is limited and should be interpreted conservatively.

Pantheon dosing guide

Application
Subcutaneous injection.
BAC Water
2 mL
Dose
1-2 mg (10-20 units)
Frequency & Cycle Length
Daily for 10 to 20 days Repeat 1-3 times yearly as needed.
Timing
Morning most common.
Key Benefits
Supports liver cell health. Supports healthy detoxification pathways. Supports cellular repair and regeneration. Promotes healthy gene-expression signaling.

Additional research protocol context

The printed guide above is Pantheon's dosing reference. These broader research examples are provided as context and may use different schedules.

  • 20 mg vial reconstituted with 2.0 mL bacteriostatic water
  • 1-2 mg subcutaneous daily
  • 10-20 day courses, repeated 1-3 times yearly as needed

Side effects

  • Injection-site redness, tenderness, itching, or mild swelling
  • Headache, fatigue, mild nausea, or digestive changes
  • Use caution with complex liver disease or prescription medication regimens

Cited studies

  1. Lezhava T, et al. (2006). Anti-aging peptide bioregulators induce reactivation of chromatin. Georgian Medical News.
    PMID 16705247Read source ↗
  2. (2020). Influence of liver polypeptide complex and KEDA tetrapeptide on physiological function in aging and pathology. PubMed.
    PMID 32362099Read source ↗
  3. Kost NV, et al. (2003). Effect of Livagen and Epitalon on enkephalin-degrading enzymes in human serum. PubMed.
    PMID 12942748Read source ↗
  4. Khavinson V, et al. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules.
    Read source ↗
Disclaimer

Content is provided for research and educational purposes only. Products are intended solely for laboratory research and are not for human use. Nothing on this page constitutes medical advice.